Compston A
J Neurol Neurosurg Psychiatry. 1983 Feb;46(2):105-14. doi: 10.1136/jnnp.46.2.105.
Using monoclonal antibodies, peripheral blood helper/inducer (OKT4) and cytotoxic/suppressor (OKT8) lymphocytes were measured in 14 normal controls, 36 patients with multiple sclerosis at different stages of the disease and 15 patients with isolated optic neuritis. Thirty-four of these individuals were studied on two or more occasions at intervals up to 340 days. Patients with multiple sclerosis in relapse had low levels of OKT8 cells (14.07% +/- 3.79) compared with controls (29.42% +/- 4.69) and this abnormality returned to normal within approximately one month of the onset of new symptoms. Further changes occurred with new relapses. Low OKT8 cells were also found in patients with isolated optic neuritis (18.76 +/- 3.71) or progressive multiple sclerosis (19.91% +/- 7.96); the same pattern of recovery was seen in these two groups as in patients with multiple sclerosis in relapse. In 25% patients studied on two or more occasions after an episode of demyelination abnormalities of lymphocyte subpopulations occurred which were not accompanied by new clinical symptoms or signs. Fluctuations of this kind did not occur in controls. The findings have implications for the pathogenesis and management of patients with multiple sclerosis.
利用单克隆抗体,对14名正常对照者、36名处于疾病不同阶段的多发性硬化症患者以及15名单发性视神经炎患者的外周血辅助/诱导型(OKT4)和细胞毒性/抑制型(OKT8)淋巴细胞进行了检测。其中34人在长达340天的时间里接受了两次或更多次的研究。复发期的多发性硬化症患者的OKT8细胞水平(14.07%±3.79)低于对照组(29.42%±4.69),且这种异常在新症状出现后约一个月内恢复正常。随着新的复发,会出现进一步的变化。在孤立性视神经炎患者(18.76±3.71)或进行性多发性硬化症患者(19.91%±7.96)中也发现了低水平的OKT8细胞;这两组患者与复发期的多发性硬化症患者表现出相同的恢复模式。在25%经历过脱髓鞘发作且接受了两次或更多次研究的患者中,出现了淋巴细胞亚群异常,但未伴有新的临床症状或体征。对照组未出现此类波动。这些发现对多发性硬化症患者的发病机制和治疗具有启示意义。